© 2024 MergersCorp M&A International.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
这家制药公司在约旦安曼成立,已有 40 年左右的历史。 它拥有 70 多项专利,在创新方面保持着区域标杆。
作为这一创新的直接结果,通过将成熟的技术平台分拆为拥有独立管理和资源的子公司,业务在传统仿制药行业之外实现了多元化。
1.核心品牌仿制药业务。
2.通过子公司天然产物。
3.通过子公司进行生物技术诊断。
4. 通过子公司开发新型赋形剂和给药系统。
产品涵盖广泛的治疗类别,包括心血管、胃肠道、中枢神经系统、抗感染、内分泌、肌肉骨骼、呼吸、产科、妇科和泌尿道以及免疫系统。
它提供 200 多种药品,满足消费者和医疗保健专业人员的需求。 这些产品包括片剂、胶囊、栓剂、糖浆和混悬剂,均按照良好生产规范 (GMP) 生产。 该公司具有竞争优势,使其成为领先的制药公司之一,因为其产品具有高“质量”。
它被誉为中东最好的公司之一,专门利用标准化药用植物提取物开发和生产植物和草药产品,提供 50 多种天然和草药创新产品,业务遍及全球 20 多个国家 。
它是一家专门从事生产专有生物技术保健产品的开发商和生产商。
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
This website is operated by MergersUS Inc a US Corporation with registered office at
报错: 未找到这个表单
报错: 未找到这个表单
报错: 未找到这个表单
报错: 未找到这个表单
描述
这家制药公司在约旦安曼成立,已有 40 年左右的历史。 它拥有 70 多项专利,在创新方面保持着区域标杆。
作为这一创新的直接结果,通过将成熟的技术平台分拆为拥有独立管理和资源的子公司,业务在传统仿制药行业之外实现了多元化。
垂直领域
1.核心品牌仿制药业务。
2.通过子公司天然产物。
3.通过子公司进行生物技术诊断。
4. 通过子公司开发新型赋形剂和给药系统。
产品
产品涵盖广泛的治疗类别,包括心血管、胃肠道、中枢神经系统、抗感染、内分泌、肌肉骨骼、呼吸、产科、妇科和泌尿道以及免疫系统。
医药业务
它提供 200 多种药品,满足消费者和医疗保健专业人员的需求。 这些产品包括片剂、胶囊、栓剂、糖浆和混悬剂,均按照良好生产规范 (GMP) 生产。 该公司具有竞争优势,使其成为领先的制药公司之一,因为其产品具有高“质量”。
天然产品
它被誉为中东最好的公司之一,专门利用标准化药用植物提取物开发和生产植物和草药产品,提供 50 多种天然和草药创新产品,业务遍及全球 20 多个国家 。
生物技术
它是一家专门从事生产专有生物技术保健产品的开发商和生产商。
Basic Details
Target Price:
$45,000,000
Gross Revenue
$37,000,000
EBITDA
$6,279,944
Business ID:
L#20230509
Country
约旦
详情
Similar Businesses
Published on 21 8 月, 2023 在 11:59 上午. 更新 8 10 月, 2023 在 2:42 上午
拥有 40 年历史的制药企业
$40,000,000
制造业, 制药, 制药, 制造业
领先的研究生物技术公司
TBA
制药
大麻农场(非精神活性大麻或休闲大麻)
$13,000,000
Medical Businesses, 制药
20年历史的制药南美品牌
$11,500,000
制造业, 制药, 制药, 制造业
历史制药制造业务
$1,050,000,000
制药
PREVIOUS PROPERTY
美国金融服务业
NEXT PROPERTY
职业完成足球俱乐部